Actively Recruiting
Improving the Prognosis for Cerebral Hemorrhage A Study of Clinical, Biological, and Imaging Markers
Led by University Hospital, Tours · Updated on 2026-05-06
10000
Participants Needed
4
Research Sites
520 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will establish a prospective, multicenter national cohort of patients with spontaneous intracerebral hemorrhage (ICH). A standardized multimodal database integrating clinical, biological, and imaging data will be collected. The study aims to better characterize ICH patient phenotypes, identify diagnostic and prognostic biomarkers, and describe adherence to evidence-based acute management strategies, including the proportion of patients managed according to the care bundle validated in the INTERACT 3 study. The cohort is also intended to provide a structured platform for translational research and the preparation of future stratified interventional clinical trials in spontaneous ICH.
CONDITIONS
Official Title
Improving the Prognosis for Cerebral Hemorrhage A Study of Clinical, Biological, and Imaging Markers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 265 18 years
- Emergency admission to a participating center, with spontaneous intracerebral hemorrhage confirmed by the first brain imaging (CT or MRI) performed at the time of initial treatment
- Obtaining non-opposition
You will not qualify if you...
- First brain imaging performed outside a center participating in the study (e.g., peripheral center not recruiting)
- Intracerebral hemorrhage secondary to another identified condition, including:
- vascular malformation (aneurysm, arteriovenous malformation, cavernoma, etc.)
- intracranial tumor
- hemorrhagic transformation of a cerebral infarction
- recent head trauma
- Patient under legal protection
- Patient under guardianship or conservatorship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
university hospital, Angers
Angers, France, 49000
Not Yet Recruiting
2
university hospital, Lille
Lille, France, 59000
Not Yet Recruiting
3
University hospital, Toulouse
Toulouse, France, 31000
Not Yet Recruiting
4
University hospital
Tours, France, 37000
Actively Recruiting
Research Team
M
Marco PASI, Pr
CONTACT
S
Sophie QUERAUD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here